OPTN and glaucoma: Mutations in optineurin (OPTN) associated with primary open angle glaucoma (E50K) reduced the phosphorylation of IRF3 and IFNα/β release assays in response to poly (I:C) stimulation of TLR3 (O'loughlin et al., 2020).